Genpact Limited (NYSE:G) – Investment analysts at SunTrust Banks lowered their Q3 2017 EPS estimates for shares of Genpact Limited in a research note issued on Thursday. SunTrust Banks analyst F. Atkins now expects that the business services provider will post earnings of $0.36 per share for the quarter, down from their prior forecast of $0.37. SunTrust Banks also issued estimates for Genpact Limited’s Q4 2017 earnings at $0.39 EPS, FY2017 earnings at $1.44 EPS, Q1 2018 earnings at $0.35 EPS, Q2 2018 earnings at $0.40 EPS, Q3 2018 earnings at $0.41 EPS, FY2018 earnings at $1.61 EPS and FY2019 earnings at $1.80 EPS.

A number of other equities research analysts also recently weighed in on the company. Robert W. Baird restated an “outperform” rating and set a $34.00 price target on shares of Genpact Limited in a research report on Wednesday, August 16th. BidaskClub downgraded Genpact Limited from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 16th. Cowen and Company set a $33.00 price target on Genpact Limited and gave the company a “buy” rating in a research report on Tuesday, August 15th. Wedbush reaffirmed an “outperform” rating and set a $33.00 price objective on shares of Genpact Limited in a research note on Wednesday, August 9th. Finally, Zacks Investment Research raised Genpact Limited from a “hold” rating to a “buy” rating and set a $33.00 price objective on the stock in a research note on Tuesday, August 8th. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $31.14.

ILLEGAL ACTIVITY WARNING: This article was posted by American Banking News and is owned by of American Banking News. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/09/11/genpact-limited-g-to-post-q3-2017-earnings-of-0-36-per-share-suntrust-banks-forecasts.html.

Shares of Genpact Limited (NYSE:G) opened at 27.97 on Monday. Genpact Limited has a 52-week low of $22.58 and a 52-week high of $31.93. The company has a market cap of $5.40 billion, a price-to-earnings ratio of 21.13 and a beta of 0.50. The firm has a 50 day moving average price of $28.75 and a 200-day moving average price of $26.47.

Genpact Limited (NYSE:G) last issued its quarterly earnings data on Wednesday, August 2nd. The business services provider reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.10. The business had revenue of $670.70 million for the quarter, compared to analyst estimates of $642.68 million. Genpact Limited had a return on equity of 23.33% and a net margin of 10.22%. Genpact Limited’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.

The firm also recently announced a special dividend, which will be paid on Thursday, September 21st. Investors of record on Friday, September 8th will be paid a $0.06 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a dividend yield of 0.84%. Genpact Limited’s payout ratio is presently 18.05%.

In related news, Director Amit Chandra sold 275,508 shares of the firm’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $28.72, for a total value of $7,912,589.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Mohit Thukral sold 25,000 shares of the firm’s stock in a transaction dated Friday, August 25th. The stock was sold at an average price of $28.37, for a total value of $709,250.00. Following the completion of the sale, the insider now directly owns 85,305 shares in the company, valued at $2,420,102.85. The disclosure for this sale can be found here. Insiders sold 10,358,442 shares of company stock worth $297,475,276 over the last three months. 1.55% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. YorkBridge Wealth Partners LLC boosted its position in Genpact Limited by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock valued at $106,000 after acquiring an additional 189 shares in the last quarter. SG Americas Securities LLC bought a new stake in Genpact Limited during the 1st quarter valued at approximately $110,000. Acrospire Investment Management LLC boosted its position in Genpact Limited by 569.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 4,019 shares of the business services provider’s stock valued at $112,000 after acquiring an additional 3,419 shares in the last quarter. Bronfman E.L. Rothschild L.P. boosted its position in Genpact Limited by 42.5% during the 1st quarter. Bronfman E.L. Rothschild L.P. now owns 4,959 shares of the business services provider’s stock valued at $123,000 after acquiring an additional 1,480 shares in the last quarter. Finally, BNP Paribas Arbitrage SA boosted its position in Genpact Limited by 85.3% during the 1st quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 2,403 shares in the last quarter. 92.16% of the stock is currently owned by institutional investors.

About Genpact Limited

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Earnings History and Estimates for Genpact Limited (NYSE:G)

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.